| Announce Date | 12/31/2022 |
| EPS Normalized Actual | $1.09 (Miss by $-0.31) |
| EPS GAAP Actual | $1.09 (Miss by $-0.31) |
| Revenue Actual | $7.998B |
| Revenue Surprise | Beat by $7998M |
| Announce Date | 12/31/1969 (Pre-Market) |
| EPS Normalized Estimate | $ |
| EPS GAAP Estimate | $ |
| Revenue Estimate | $0B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2023 | 10.96 | 2.25 | 10.96 | 10.96 | 1 |
| Dec 2022 | 9.7555 | 2.52 | 9.7555 | 9.7555 | 1 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 0 | 0 | 7.998B | 18.45% | 7998M |
| FQ2 2025 (Jun 2025) | 0 | 0 | 5.359B | 12.97% | 5359M |
| FQ1 2025 (Mar 2025) | 2.282 | 2.282 | 4.186B | -36.67% | 4186M |
| FQ4 2024 (Dec 2024) | 0 | 0 | 3.782B | -167.32% | 3782M |
| FQ3 2024 (Sep 2024) | 0 | 0 | 6.522B | 77.98% | 6522M |
| FQ2 2024 (Jun 2024) | 0 | 0 | 4.664B | -174.38% | 4664M |
| FQ4 2023 (Dec 2023) | 9.47 | 9.47 | 10.11B | 62.53% | 10110M |
| FQ1 2024 (Mar 2024) | 3.8 | 3.8 | 5.721B | 29.03% | 5721M |
FQ4 Announce Date
12/31/1969 (Pre-Market)
Consensus EPS Estimates
Consensus Revenue Estimates
0B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ3 2029 (Sep 2029) | 2.66667 | -- | 2.66667 | 2.66667 | 1 |
| FQ2 2029 (Jun 2029) | 2.66667 | -- | 2.66667 | 2.66667 | 1 |
| FQ1 2029 (Mar 2029) | 2.62 | -- | 2.62 | 2.62 | 1 |
| FQ4 2028 (Dec 2028) | 2.54667 | -- | 2.54667 | 2.54667 | 1 |
| FQ3 2028 (Sep 2028) | 2.54667 | -- | 2.54667 | 2.54667 | 1 |
| FQ2 2028 (Jun 2028) | 2.51 | -- | 2.51 | 2.51 | 1 |
| FQ1 2028 (Mar 2028) | 2.51084 | -- | 2.51084 | 2.51084 | 1 |
| FQ4 2027 (Dec 2027) | 2.35511 | -- | 2.35511 | 2.35511 | 1 |
| FQ3 2027 (Sep 2027) | 2.35511 | -- | 2.35511 | 2.35511 | 1 |
| FQ2 2027 (Jun 2027) | 2.27221 | -- | 2.27221 | 2.27221 | 1 |
| FQ1 2027 (Mar 2027) | 2.0976 | -- | 2.0976 | 2.0976 | 1 |
| FQ4 2026 (Dec 2026) | 2.0976 | -- | 2.0976 | 2.0976 | 1 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ3 2029 (Sep 2029) | 16.56B | -- | 16.56B | 16.56B | 1 |
| FQ2 2029 (Jun 2029) | 15.82B | -- | 15.82B | 15.82B | 1 |
| FQ1 2029 (Mar 2029) | 15.12B | -- | 15.12B | 15.12B | 1 |
| FQ4 2028 (Dec 2028) | 14.44B | -- | 14.44B | 14.44B | 1 |
| FQ3 2028 (Sep 2028) | 7.91B | -- | 7.91B | 7.91B | 1 |
| FQ2 2028 (Jun 2028) | 7.56B | -- | 7.56B | 7.56B | 1 |
| FQ1 2028 (Mar 2028) | 1.79B | -- | 1.79B | 1.79B | 1 |
| FQ4 2027 (Dec 2027) | 1.73B | -- | 1.73B | 1.73B | 1 |
| FQ3 2027 (Sep 2027) | 1.73B | -- | 1.73B | 1.73B | 1 |
| FQ2 2027 (Jun 2027) | 1.67B | -- | 1.67B | 1.67B | 1 |
| FQ1 2027 (Mar 2027) | 1.59B | -- | 1.59B | 1.59B | 1 |
| FQ4 2026 (Dec 2026) | 1.59B | -- | 1.59B | 1.59B | 1 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
3
EPS # of Misses
0
EPS # of in-lines
5
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 0 | 0 | NAN% | |
| FQ2 2025 (Jun 2025) | 0 | 0 | NAN% | |
| FQ1 2025 (Mar 2025) | 2.282 | 2.282 | 100% | |
| FQ4 2024 (Dec 2024) | 0 | 0 | NAN% | |
| FQ3 2024 (Sep 2024) | 0 | 0 | NAN% | |
| FQ2 2024 (Jun 2024) | 0 | 0 | NAN% | |
| FQ4 2023 (Dec 2023) | 9.47 | 9.47 | 100% | |
| FQ1 2024 (Mar 2024) | 3.8 | 3.8 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | $0B | $8B | $7998M | 100% |
| FQ2 2025 (Jun 2025) | $0B | $5.36B | $5359M | 100% |
| FQ1 2025 (Mar 2025) | $0B | $4.19B | $4186M | 100% |
| FQ4 2024 (Dec 2024) | $0B | $3.78B | $3782M | 100% |
| FQ3 2024 (Sep 2024) | $0B | $6.52B | $6522M | 100% |
| FQ2 2024 (Jun 2024) | $0B | $4.66B | $4664M | 100% |
| FQ4 2023 (Dec 2023) | $0B | $10.11B | $10110M | 100% |
| FQ1 2024 (Mar 2024) | $0B | $5.72B | $5721M | 100% |